Evangelos Messaris, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colectomy | 26 | 2023 | 696 | 5.590 |
Why?
|
Rectal Neoplasms | 9 | 2023 | 1183 | 2.800 |
Why?
|
Colorectal Surgery | 6 | 2022 | 125 | 2.630 |
Why?
|
Crohn Disease | 12 | 2024 | 2286 | 2.460 |
Why?
|
Laparoscopy | 12 | 2023 | 2039 | 2.110 |
Why?
|
Ileostomy | 8 | 2023 | 122 | 2.050 |
Why?
|
Colitis, Ulcerative | 10 | 2023 | 1920 | 2.030 |
Why?
|
Digestive System Surgical Procedures | 5 | 2022 | 584 | 1.630 |
Why?
|
Rectum | 6 | 2020 | 896 | 1.430 |
Why?
|
Rectal Diseases | 3 | 2021 | 141 | 1.310 |
Why?
|
Gastrointestinal Agents | 4 | 2024 | 511 | 1.290 |
Why?
|
Colonic Diseases | 3 | 2021 | 204 | 1.270 |
Why?
|
Colonic Neoplasms | 6 | 2023 | 2534 | 1.270 |
Why?
|
Anastomotic Leak | 6 | 2023 | 170 | 1.100 |
Why?
|
Postoperative Complications | 26 | 2024 | 15831 | 1.080 |
Why?
|
Sigmoid Diseases | 3 | 2015 | 61 | 1.050 |
Why?
|
Ileum | 4 | 2022 | 558 | 1.050 |
Why?
|
Neuroendocrine Tumors | 2 | 2024 | 659 | 1.030 |
Why?
|
Surgical Stapling | 2 | 2022 | 98 | 0.970 |
Why?
|
Rectal Prolapse | 1 | 2024 | 33 | 0.880 |
Why?
|
Hypoalbuminemia | 1 | 2023 | 90 | 0.830 |
Why?
|
Sepsis | 10 | 2013 | 2604 | 0.810 |
Why?
|
Diverticulitis, Colonic | 2 | 2022 | 140 | 0.810 |
Why?
|
Diverticulitis | 2 | 2015 | 187 | 0.800 |
Why?
|
Intestinal Neoplasms | 2 | 2024 | 314 | 0.770 |
Why?
|
Umbilicus | 1 | 2022 | 38 | 0.770 |
Why?
|
Anastomosis, Surgical | 8 | 2022 | 992 | 0.760 |
Why?
|
Hernia, Ventral | 2 | 2015 | 220 | 0.750 |
Why?
|
Proctocolectomy, Restorative | 6 | 2023 | 191 | 0.740 |
Why?
|
Fecal Incontinence | 1 | 2024 | 246 | 0.740 |
Why?
|
Suture Techniques | 2 | 2022 | 775 | 0.720 |
Why?
|
Colorectal Neoplasms | 7 | 2024 | 6962 | 0.700 |
Why?
|
Protein C | 3 | 2010 | 134 | 0.660 |
Why?
|
Intra-Abdominal Fat | 2 | 2015 | 624 | 0.650 |
Why?
|
Colon | 4 | 2022 | 1797 | 0.650 |
Why?
|
Retrospective Studies | 45 | 2024 | 81635 | 0.640 |
Why?
|
Ileocecal Valve | 1 | 2018 | 22 | 0.630 |
Why?
|
Preoperative Care | 5 | 2021 | 2253 | 0.600 |
Why?
|
Neoadjuvant Therapy | 5 | 2023 | 2902 | 0.590 |
Why?
|
Intestine, Small | 1 | 2024 | 1217 | 0.590 |
Why?
|
Venous Thromboembolism | 4 | 2022 | 1882 | 0.550 |
Why?
|
Inflammatory Bowel Diseases | 6 | 2022 | 2429 | 0.550 |
Why?
|
Biological Factors | 1 | 2017 | 155 | 0.530 |
Why?
|
Neoplasms, Second Primary | 1 | 2023 | 1061 | 0.500 |
Why?
|
Apoptosis | 8 | 2013 | 9513 | 0.450 |
Why?
|
Specialization | 1 | 2019 | 779 | 0.450 |
Why?
|
Length of Stay | 8 | 2021 | 6490 | 0.440 |
Why?
|
5'-Nucleotidase | 1 | 2014 | 163 | 0.430 |
Why?
|
Bupivacaine | 1 | 2017 | 414 | 0.430 |
Why?
|
Colonic Polyps | 1 | 2018 | 557 | 0.430 |
Why?
|
Humans | 88 | 2024 | 766766 | 0.430 |
Why?
|
Peripheral Nerves | 1 | 2017 | 490 | 0.430 |
Why?
|
Abdominal Abscess | 1 | 2014 | 152 | 0.410 |
Why?
|
Clostridium Infections | 2 | 2017 | 563 | 0.410 |
Why?
|
Multiple Organ Failure | 1 | 2014 | 389 | 0.390 |
Why?
|
Ileitis | 1 | 2011 | 40 | 0.380 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3853 | 0.370 |
Why?
|
Subcutaneous Fat | 1 | 2014 | 401 | 0.370 |
Why?
|
Middle Aged | 46 | 2024 | 223257 | 0.360 |
Why?
|
Male | 58 | 2024 | 364142 | 0.360 |
Why?
|
Aged | 37 | 2024 | 171343 | 0.360 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1394 | 0.350 |
Why?
|
Dehydration | 1 | 2012 | 216 | 0.350 |
Why?
|
Rats, Wistar | 9 | 2010 | 1889 | 0.340 |
Why?
|
Postoperative Period | 3 | 2022 | 1824 | 0.340 |
Why?
|
Anesthetics, Local | 1 | 2017 | 1005 | 0.340 |
Why?
|
Nerve Block | 1 | 2017 | 717 | 0.340 |
Why?
|
Adult | 42 | 2024 | 223307 | 0.330 |
Why?
|
Wounds, Nonpenetrating | 2 | 2014 | 807 | 0.330 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1946 | 0.330 |
Why?
|
Colostomy | 2 | 2022 | 107 | 0.320 |
Why?
|
Anus Neoplasms | 1 | 2013 | 336 | 0.320 |
Why?
|
Databases, Factual | 7 | 2024 | 8066 | 0.320 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2013 | 594 | 0.310 |
Why?
|
Immunologic Factors | 1 | 2018 | 1594 | 0.310 |
Why?
|
Neoplasm Staging | 9 | 2023 | 11218 | 0.310 |
Why?
|
Colon, Sigmoid | 2 | 2022 | 124 | 0.300 |
Why?
|
General Surgery | 2 | 2020 | 1720 | 0.300 |
Why?
|
Treatment Outcome | 17 | 2024 | 65273 | 0.290 |
Why?
|
Female | 51 | 2024 | 396520 | 0.290 |
Why?
|
Pancreatitis | 1 | 2014 | 1087 | 0.290 |
Why?
|
Hospital Costs | 1 | 2014 | 955 | 0.290 |
Why?
|
Lipopolysaccharides | 2 | 2013 | 2214 | 0.290 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2017 | 4349 | 0.290 |
Why?
|
Cecum | 3 | 2018 | 231 | 0.280 |
Why?
|
Hernia, Inguinal | 1 | 2010 | 224 | 0.280 |
Why?
|
Colonic Pouches | 2 | 2019 | 122 | 0.280 |
Why?
|
Patient Compliance | 1 | 2017 | 2694 | 0.270 |
Why?
|
Cytochromes c | 5 | 2009 | 173 | 0.270 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 5 | 2009 | 1405 | 0.270 |
Why?
|
bcl-2-Associated X Protein | 6 | 2009 | 281 | 0.270 |
Why?
|
Gelsolin | 1 | 2007 | 189 | 0.260 |
Why?
|
Colitis | 2 | 2012 | 1238 | 0.260 |
Why?
|
Patient Admission | 2 | 2013 | 1364 | 0.260 |
Why?
|
Pain, Postoperative | 1 | 2017 | 1768 | 0.260 |
Why?
|
Kidney Tubules | 1 | 2008 | 454 | 0.260 |
Why?
|
Leukocytes | 1 | 2014 | 2035 | 0.260 |
Why?
|
Caspase 8 | 4 | 2008 | 198 | 0.250 |
Why?
|
Statistics, Nonparametric | 5 | 2022 | 2846 | 0.240 |
Why?
|
Risk Factors | 15 | 2024 | 74881 | 0.240 |
Why?
|
Propensity Score | 3 | 2019 | 1972 | 0.240 |
Why?
|
Surgical Wound Infection | 1 | 2014 | 1547 | 0.240 |
Why?
|
Aged, 80 and over | 17 | 2022 | 59550 | 0.240 |
Why?
|
Fibrinolysis | 1 | 2006 | 331 | 0.240 |
Why?
|
Endotoxemia | 1 | 2006 | 198 | 0.240 |
Why?
|
Patient Readmission | 4 | 2015 | 3283 | 0.230 |
Why?
|
Gastric Mucosa | 1 | 2007 | 602 | 0.220 |
Why?
|
Adenocarcinoma | 2 | 2018 | 6359 | 0.220 |
Why?
|
Colonoscopy | 2 | 2022 | 1409 | 0.220 |
Why?
|
Deferoxamine | 1 | 2004 | 155 | 0.220 |
Why?
|
Free Radical Scavengers | 1 | 2004 | 213 | 0.210 |
Why?
|
Regression Analysis | 2 | 2024 | 6329 | 0.210 |
Why?
|
Cohort Studies | 10 | 2021 | 41710 | 0.210 |
Why?
|
Iron Chelating Agents | 1 | 2004 | 141 | 0.210 |
Why?
|
Young Adult | 11 | 2024 | 59939 | 0.210 |
Why?
|
Purkinje Cells | 1 | 2004 | 228 | 0.200 |
Why?
|
Swine | 2 | 2022 | 5987 | 0.200 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7871 | 0.190 |
Why?
|
Disease Models, Animal | 6 | 2014 | 18330 | 0.190 |
Why?
|
Neutrophils | 2 | 2014 | 3782 | 0.190 |
Why?
|
Microfilament Proteins | 1 | 2007 | 1129 | 0.190 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2007 | 621 | 0.190 |
Why?
|
Choroid Plexus | 1 | 2004 | 249 | 0.190 |
Why?
|
Multivariate Analysis | 6 | 2022 | 12064 | 0.180 |
Why?
|
Lymphatic Metastasis | 4 | 2018 | 2901 | 0.180 |
Why?
|
Neoplasm Invasiveness | 3 | 2018 | 3609 | 0.170 |
Why?
|
Blood Coagulation | 1 | 2006 | 1163 | 0.170 |
Why?
|
Rats | 10 | 2010 | 23717 | 0.170 |
Why?
|
Jejunum | 1 | 2022 | 474 | 0.170 |
Why?
|
Industry | 1 | 2022 | 362 | 0.170 |
Why?
|
Intensive Care Units | 1 | 2013 | 3799 | 0.170 |
Why?
|
Accreditation | 1 | 2023 | 476 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9404 | 0.160 |
Why?
|
Constipation | 1 | 2024 | 568 | 0.160 |
Why?
|
In Situ Nick-End Labeling | 3 | 2010 | 610 | 0.160 |
Why?
|
Inflammation | 3 | 2022 | 10860 | 0.160 |
Why?
|
Recurrence | 4 | 2022 | 8507 | 0.150 |
Why?
|
Quality Improvement | 4 | 2023 | 3850 | 0.140 |
Why?
|
Cytokines | 2 | 2010 | 7438 | 0.140 |
Why?
|
Bibliometrics | 1 | 2021 | 355 | 0.140 |
Why?
|
Conflict of Interest | 1 | 2022 | 556 | 0.140 |
Why?
|
Minority Groups | 1 | 2024 | 1208 | 0.130 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11920 | 0.130 |
Why?
|
Abdominal Muscles | 1 | 2017 | 172 | 0.130 |
Why?
|
Pennsylvania | 1 | 2017 | 615 | 0.130 |
Why?
|
Cicatrix | 1 | 2022 | 798 | 0.130 |
Why?
|
Survival Analysis | 7 | 2017 | 10100 | 0.130 |
Why?
|
Income | 1 | 2024 | 1875 | 0.130 |
Why?
|
Survival Rate | 6 | 2018 | 12825 | 0.130 |
Why?
|
Hernia, Abdominal | 2 | 2014 | 58 | 0.130 |
Why?
|
United States | 8 | 2024 | 72951 | 0.130 |
Why?
|
Genes, bcl-2 | 3 | 2004 | 119 | 0.120 |
Why?
|
Interdisciplinary Communication | 1 | 2021 | 932 | 0.120 |
Why?
|
Intestinal Obstruction | 2 | 2011 | 433 | 0.120 |
Why?
|
Random Allocation | 3 | 2010 | 2394 | 0.120 |
Why?
|
Animals | 15 | 2022 | 168930 | 0.120 |
Why?
|
Emergencies | 2 | 2019 | 1223 | 0.120 |
Why?
|
Adolescent | 10 | 2020 | 88904 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20708 | 0.120 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3432 | 0.120 |
Why?
|
Patient Selection | 2 | 2010 | 4252 | 0.120 |
Why?
|
Collagen | 1 | 2022 | 2635 | 0.120 |
Why?
|
Patients' Rooms | 1 | 2014 | 63 | 0.110 |
Why?
|
Prognosis | 8 | 2018 | 29948 | 0.110 |
Why?
|
Predictive Value of Tests | 4 | 2015 | 15416 | 0.110 |
Why?
|
Follow-Up Studies | 6 | 2018 | 39309 | 0.110 |
Why?
|
Caspases | 3 | 2009 | 881 | 0.110 |
Why?
|
Acute Disease | 1 | 2024 | 7241 | 0.110 |
Why?
|
Body Fat Distribution | 1 | 2014 | 246 | 0.110 |
Why?
|
Liposomes | 1 | 2017 | 787 | 0.100 |
Why?
|
Registries | 4 | 2020 | 8351 | 0.100 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 2270 | 0.100 |
Why?
|
Mental Health | 2 | 2024 | 3270 | 0.100 |
Why?
|
Medical Order Entry Systems | 1 | 2017 | 523 | 0.100 |
Why?
|
Obesity | 1 | 2014 | 13090 | 0.100 |
Why?
|
Adenoma | 1 | 2022 | 2155 | 0.100 |
Why?
|
Gene Expression | 2 | 2004 | 7585 | 0.100 |
Why?
|
Hospital Charges | 1 | 2014 | 345 | 0.100 |
Why?
|
Time Factors | 6 | 2021 | 40149 | 0.100 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 195 | 0.100 |
Why?
|
Hippocampus | 1 | 2004 | 3776 | 0.090 |
Why?
|
Accidents, Traffic | 2 | 2008 | 818 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3804 | 0.090 |
Why?
|
Intestinal Fistula | 1 | 2011 | 146 | 0.090 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 615 | 0.090 |
Why?
|
Ischemia | 2 | 2011 | 1905 | 0.090 |
Why?
|
Flow Cytometry | 3 | 2010 | 5890 | 0.090 |
Why?
|
Camptothecin | 1 | 2013 | 599 | 0.080 |
Why?
|
Intestines | 2 | 2011 | 1904 | 0.080 |
Why?
|
Seroma | 1 | 2010 | 75 | 0.080 |
Why?
|
Organ Size | 1 | 2015 | 2261 | 0.080 |
Why?
|
Cellulitis | 1 | 2011 | 206 | 0.080 |
Why?
|
Calcitonin | 1 | 2011 | 327 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 2 | 2023 | 36567 | 0.080 |
Why?
|
Tissue Adhesions | 3 | 2007 | 222 | 0.080 |
Why?
|
Mice | 3 | 2022 | 81889 | 0.080 |
Why?
|
Blood Loss, Surgical | 2 | 2011 | 642 | 0.080 |
Why?
|
Serum Albumin | 1 | 2012 | 675 | 0.080 |
Why?
|
Ligation | 1 | 2010 | 446 | 0.080 |
Why?
|
Remission Induction | 1 | 2014 | 2413 | 0.080 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15908 | 0.080 |
Why?
|
Keratin-18 | 1 | 2008 | 37 | 0.080 |
Why?
|
Quality Assurance, Health Care | 1 | 2019 | 2171 | 0.080 |
Why?
|
Cytoprotection | 1 | 2009 | 199 | 0.080 |
Why?
|
Logistic Models | 2 | 2014 | 13278 | 0.080 |
Why?
|
Secondary Prevention | 1 | 2014 | 1469 | 0.070 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2008 | 220 | 0.070 |
Why?
|
Immunohistochemistry | 4 | 2010 | 11061 | 0.070 |
Why?
|
Catheterization | 2 | 2005 | 1429 | 0.070 |
Why?
|
Abscess | 1 | 2011 | 606 | 0.070 |
Why?
|
Drug Monitoring | 1 | 2013 | 962 | 0.070 |
Why?
|
Operating Rooms | 1 | 2014 | 790 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2693 | 0.070 |
Why?
|
Proton Pump Inhibitors | 1 | 2012 | 550 | 0.070 |
Why?
|
Surgical Mesh | 1 | 2010 | 315 | 0.070 |
Why?
|
Transcriptional Activation | 1 | 2013 | 1749 | 0.070 |
Why?
|
Protein Precursors | 1 | 2011 | 1134 | 0.070 |
Why?
|
Neurons | 2 | 2009 | 9515 | 0.060 |
Why?
|
Odds Ratio | 2 | 2017 | 9661 | 0.060 |
Why?
|
Medication Adherence | 1 | 2017 | 2190 | 0.060 |
Why?
|
Drug Costs | 1 | 2014 | 1195 | 0.060 |
Why?
|
Forkhead Transcription Factors | 1 | 2013 | 1627 | 0.060 |
Why?
|
bcl-X Protein | 1 | 2007 | 412 | 0.060 |
Why?
|
Multiple Trauma | 1 | 2008 | 369 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3459 | 0.060 |
Why?
|
Research Design | 1 | 2001 | 6207 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1805 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9602 | 0.060 |
Why?
|
Intestinal Perforation | 1 | 2007 | 254 | 0.060 |
Why?
|
Peritoneal Cavity | 1 | 2005 | 135 | 0.060 |
Why?
|
Microscopy, Electron | 1 | 2008 | 2551 | 0.060 |
Why?
|
Probability | 1 | 2010 | 2476 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2013 | 2456 | 0.060 |
Why?
|
Cell Nucleus | 1 | 2013 | 2870 | 0.060 |
Why?
|
Immunoenzyme Techniques | 1 | 2007 | 1697 | 0.060 |
Why?
|
Motor Vehicles | 1 | 2006 | 280 | 0.060 |
Why?
|
Medicare | 1 | 2022 | 6820 | 0.050 |
Why?
|
Anxiety | 1 | 2018 | 4670 | 0.050 |
Why?
|
Prospective Studies | 6 | 2023 | 54871 | 0.050 |
Why?
|
Genes, fos | 1 | 2003 | 176 | 0.050 |
Why?
|
Up-Regulation | 2 | 2013 | 4142 | 0.050 |
Why?
|
Comorbidity | 1 | 2017 | 10580 | 0.050 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2001 | 755 | 0.050 |
Why?
|
Anticoagulants | 1 | 2017 | 4855 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13476 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2017 | 22248 | 0.050 |
Why?
|
Peritoneal Diseases | 1 | 2002 | 76 | 0.050 |
Why?
|
Linear Models | 2 | 2022 | 5874 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3837 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26310 | 0.040 |
Why?
|
Genes, p53 | 1 | 2003 | 711 | 0.040 |
Why?
|
Spleen | 1 | 2006 | 2295 | 0.040 |
Why?
|
Spermatic Cord | 1 | 2000 | 23 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 2 | 2004 | 4522 | 0.040 |
Why?
|
Radiology | 1 | 2014 | 2105 | 0.040 |
Why?
|
Cytoplasm | 1 | 2004 | 1505 | 0.040 |
Why?
|
Genital Neoplasms, Male | 1 | 2000 | 68 | 0.040 |
Why?
|
Incidence | 2 | 2015 | 21525 | 0.040 |
Why?
|
Liver | 2 | 2006 | 7571 | 0.040 |
Why?
|
Germinoma | 1 | 2000 | 132 | 0.040 |
Why?
|
Macrophages, Alveolar | 1 | 2001 | 413 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6512 | 0.040 |
Why?
|
Medically Uninsured | 1 | 2024 | 838 | 0.040 |
Why?
|
Medical Audit | 1 | 2020 | 454 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2022 | 3552 | 0.040 |
Why?
|
Greece | 3 | 2006 | 341 | 0.040 |
Why?
|
Erythropoietin | 1 | 2003 | 718 | 0.040 |
Why?
|
Depression | 1 | 2018 | 8228 | 0.040 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2002 | 391 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2001 | 1606 | 0.030 |
Why?
|
Body Mass Index | 1 | 2014 | 13050 | 0.030 |
Why?
|
Intraoperative Complications | 1 | 2023 | 1171 | 0.030 |
Why?
|
Antineoplastic Agents | 3 | 2022 | 13643 | 0.030 |
Why?
|
Sex Factors | 1 | 2010 | 10619 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2006 | 3227 | 0.030 |
Why?
|
Age Factors | 2 | 2010 | 18397 | 0.030 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2003 | 957 | 0.030 |
Why?
|
Necrosis | 2 | 2011 | 1616 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2024 | 2116 | 0.030 |
Why?
|
Hospital Mortality | 2 | 2024 | 5343 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2013 | 11872 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 7475 | 0.030 |
Why?
|
Program Development | 1 | 2019 | 1297 | 0.030 |
Why?
|
Language | 1 | 2022 | 1550 | 0.030 |
Why?
|
Injury Severity Score | 2 | 2008 | 1049 | 0.030 |
Why?
|
Insurance Coverage | 1 | 2024 | 1945 | 0.030 |
Why?
|
Wounds and Injuries | 1 | 2006 | 2513 | 0.030 |
Why?
|
Respiratory Insufficiency | 1 | 2001 | 1241 | 0.030 |
Why?
|
Melanoma | 2 | 2002 | 5700 | 0.030 |
Why?
|
Polyurethanes | 2 | 2005 | 110 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2000 | 1374 | 0.030 |
Why?
|
Bystander Effect | 1 | 2013 | 89 | 0.030 |
Why?
|
Silicones | 2 | 2005 | 228 | 0.030 |
Why?
|
Polytetrafluoroethylene | 2 | 2005 | 242 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 12534 | 0.020 |
Why?
|
Insurance, Health | 1 | 2024 | 2520 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2013 | 406 | 0.020 |
Why?
|
Neoplasms | 1 | 2001 | 22350 | 0.020 |
Why?
|
Leucovorin | 1 | 2013 | 644 | 0.020 |
Why?
|
Medicaid | 1 | 2024 | 2836 | 0.020 |
Why?
|
Myocardium | 1 | 2004 | 4765 | 0.020 |
Why?
|
Mitochondria | 1 | 2004 | 3677 | 0.020 |
Why?
|
Trauma Centers | 2 | 2006 | 950 | 0.020 |
Why?
|
Stomach Neoplasms | 1 | 2000 | 1474 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2000 | 2948 | 0.020 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2002 | 2039 | 0.020 |
Why?
|
Thyroid Neoplasms | 1 | 2003 | 2355 | 0.020 |
Why?
|
Risk Assessment | 3 | 2022 | 24295 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3411 | 0.020 |
Why?
|
Fluorouracil | 1 | 2013 | 1651 | 0.020 |
Why?
|
Kidney | 1 | 2004 | 7074 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3236 | 0.020 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2011 | 327 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3888 | 0.020 |
Why?
|
Turkey | 1 | 2008 | 256 | 0.020 |
Why?
|
Cell Death | 1 | 2013 | 1676 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3957 | 0.020 |
Why?
|
Protein Transport | 1 | 2013 | 1942 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2013 | 3587 | 0.020 |
Why?
|
Esophageal Neoplasms | 1 | 2017 | 1660 | 0.020 |
Why?
|
Imidazoles | 1 | 2013 | 1168 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 1638 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2002 | 4049 | 0.020 |
Why?
|
Glasgow Coma Scale | 1 | 2008 | 574 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2022 | 9525 | 0.020 |
Why?
|
Motorcycles | 1 | 2006 | 42 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3607 | 0.010 |
Why?
|
Reticulocyte Count | 1 | 2003 | 36 | 0.010 |
Why?
|
Abdominal Injuries | 1 | 2006 | 362 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6850 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2002 | 5861 | 0.010 |
Why?
|
Life Tables | 1 | 2002 | 367 | 0.010 |
Why?
|
Polyvinyl Chloride | 1 | 2002 | 32 | 0.010 |
Why?
|
Brain | 1 | 2009 | 27159 | 0.010 |
Why?
|
Child | 1 | 2010 | 80668 | 0.010 |
Why?
|
Annexin A5 | 1 | 2001 | 102 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10745 | 0.010 |
Why?
|
Hematocrit | 1 | 2003 | 622 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 2001 | 238 | 0.010 |
Why?
|
Astrocytes | 1 | 2009 | 1351 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2006 | 1326 | 0.010 |
Why?
|
Pyridines | 1 | 2013 | 2888 | 0.010 |
Why?
|
Pyrimidines | 1 | 2013 | 3043 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 2002 | 1622 | 0.010 |
Why?
|
Thyroid Diseases | 1 | 2003 | 385 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2000 | 9101 | 0.010 |
Why?
|
Bleomycin | 1 | 2000 | 492 | 0.010 |
Why?
|
Etoposide | 1 | 2000 | 638 | 0.010 |
Why?
|
Walking | 1 | 2006 | 1201 | 0.010 |
Why?
|
Glioblastoma | 1 | 2013 | 3458 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 2002 | 1138 | 0.010 |
Why?
|
Hemoglobins | 1 | 2003 | 1531 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2013 | 8621 | 0.010 |
Why?
|
Models, Biological | 1 | 2013 | 9461 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2013 | 17088 | 0.010 |
Why?
|
Blood Transfusion | 1 | 2003 | 1308 | 0.010 |
Why?
|
Cause of Death | 1 | 2006 | 3716 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2000 | 1615 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2000 | 1787 | 0.010 |
Why?
|
Cisplatin | 1 | 2000 | 1655 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2003 | 6507 | 0.010 |
Why?
|
Forecasting | 1 | 2002 | 2936 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23619 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2003 | 12430 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 2000 | 8540 | 0.000 |
Why?
|
Head and Neck Neoplasms | 1 | 2000 | 2929 | 0.000 |
Why?
|
Disease Progression | 1 | 2002 | 13640 | 0.000 |
Why?
|